ZhuZhou QianJin Pharmaceutical Co Ltd (600479) — Cash Flow Quality Index
ZhuZhou QianJin Pharmaceutical Co Ltd (600479) has a Cash Flow Quality Index of 4.84x as of September 2025. Operating cash flow of CN¥288.83 Million exceeds net income of CN¥59.63 Million, indicating high earnings quality where cash backs reported profits. Explore 600479 long-term investment intensity to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
ZhuZhou QianJin Pharmaceutical Co Ltd Cash Flow Quality Index (2002–2025)
Historical Cash Flow Quality Index for ZhuZhou QianJin Pharmaceutical Co Ltd across 24 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 600479 intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for ZhuZhou QianJin Pharmaceutical Co Ltd (2002–2025)
Year-by-year earnings quality comparison for ZhuZhou QianJin Pharmaceutical Co Ltd. For live market cap and the full company financial profile, see 600479 stock market capitalisation.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.68x | CN¥480.24 Million | CN¥286.29 Million | ▲ +27.3% |
| 2024 | 1.32x | CN¥398.77 Million | CN¥302.61 Million | ▲ +17.5% |
| 2023 | 1.12x | CN¥443.12 Million | CN¥395.02 Million | ▼ -53.7% |
| 2022 | 2.42x | CN¥733.47 Million | CN¥302.51 Million | ▲ +50.8% |
| 2021 | 1.61x | CN¥485.57 Million | CN¥302.06 Million | ▲ +6.8% |
| 2020 | 1.51x | CN¥542.37 Million | CN¥360.21 Million | ▲ +241.0% |
| 2019 | 0.44x | CN¥155.49 Million | CN¥352.10 Million | ▼ -65.2% |
| 2018 | 1.27x | CN¥383.47 Million | CN¥302.56 Million | ▲ +10.3% |
| 2017 | 1.15x | CN¥283.47 Million | CN¥246.66 Million | ▲ +41.4% |
| 2016 | 0.81x | CN¥140.88 Million | CN¥173.36 Million | ▲ +6.4% |
| 2015 | 0.76x | CN¥67.48 Million | CN¥88.34 Million | ▼ -51.0% |
| 2014 | 1.56x | CN¥183.34 Million | CN¥117.70 Million | ▲ +45.8% |
| 2013 | 1.07x | CN¥137.63 Million | CN¥128.78 Million | ▼ -29.3% |
| 2012 | 1.51x | CN¥197.82 Million | CN¥130.91 Million | ▲ +534.3% |
| 2011 | 0.24x | CN¥22.58 Million | CN¥94.77 Million | ▼ -40.6% |
| 2010 | 0.40x | CN¥39.13 Million | CN¥97.58 Million | ▼ -25.3% |
| 2009 | 0.54x | CN¥73.54 Million | CN¥136.91 Million | ▲ +94.2% |
| 2008 | 0.28x | CN¥37.20 Million | CN¥134.49 Million | ▼ -38.4% |
| 2007 | 0.45x | CN¥79.26 Million | CN¥176.59 Million | ▼ -72.0% |
| 2006 | 1.60x | CN¥120.12 Million | CN¥74.96 Million | ▲ +29.3% |
| 2005 | 1.24x | CN¥76.50 Million | CN¥61.72 Million | ▲ +212.9% |
| 2004 | 0.40x | CN¥18.45 Million | CN¥46.58 Million | ▼ -62.3% |
| 2003 | 1.05x | CN¥50.96 Million | CN¥48.43 Million | ▲ +574.6% |
| 2002 | 0.16x | CN¥6.07 Million | CN¥38.95 Million | — |